LUCCHESI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 198
EU - Europa 67
AS - Asia 10
SA - Sud America 3
AF - Africa 1
OC - Oceania 1
Totale 280
Nazione #
US - Stati Uniti d'America 198
FR - Francia 18
IE - Irlanda 12
IT - Italia 11
BE - Belgio 4
DE - Germania 4
GB - Regno Unito 4
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
VN - Vietnam 3
BG - Bulgaria 2
CH - Svizzera 2
EC - Ecuador 2
FI - Finlandia 2
SE - Svezia 2
AU - Australia 1
CL - Cile 1
CN - Cina 1
IN - India 1
JP - Giappone 1
NL - Olanda 1
PL - Polonia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 280
Città #
Ashburn 21
Santa Cruz 20
Chandler 13
Dublin 12
Buffalo 11
Cambridge 7
Mountain View 7
Woodbridge 7
Seattle 6
Fairfield 5
Houston 5
Boardman 4
Brussels 4
Fleming Island 4
Southend 4
Bologna 3
San Diego 3
Ann Arbor 2
Bern 2
Brockport 2
Brooklyn 2
Clearwater 2
Forlì 2
Helsinki 2
Loja 2
Los Angeles 2
Sofia 2
Stockholm 2
Atlanta 1
Beijing 1
Cedar Knolls 1
Chicago 1
Dong Ket 1
Esslingen am Neckar 1
Florence 1
Herndon 1
Las Vegas 1
Milpitas 1
Munich 1
Omaha 1
Pieve di Cento 1
Providence 1
Pune 1
Redmond 1
Rome 1
San Francisco 1
Scranton 1
Silverton 1
Sunnyvale 1
Tokyo 1
Totale 180
Nome #
Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients, file e1dcb332-0ac2-7715-e053-1705fe0a6cc9 66
Can early switch to rituximab-bendamustine in a patient with follicular non-Hodgkin lymphoma progressing during R-CHOP be considered frontline treatment?: A case report, file e1dcb336-638c-7715-e053-1705fe0a6cc9 64
null, file e1dcb335-7a60-7715-e053-1705fe0a6cc9 46
Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients, file e1dcb335-1c30-7715-e053-1705fe0a6cc9 23
Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients, file e1dcb335-1c2f-7715-e053-1705fe0a6cc9 18
IL-17/IL-10 double-producing T cells: New link between infections, immunosuppression and acute myeloid leukemia, file e1dcb338-8d63-7715-e053-1705fe0a6cc9 17
ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients, file e1dcb33a-1c05-7715-e053-1705fe0a6cc9 17
Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulfate: a multicentric randomized study, file e1dcb338-8f9c-7715-e053-1705fe0a6cc9 8
Immune thrombocytopenia in antiphospholipid syndrome: Is it primary or secondary?, file c71c10f2-e4a8-420c-9eab-b0c6ee46dcf2 7
Making Treatment-Free Remission (TFR) Easier in Chronic Myeloid Leukemia: Fact-Checking and Practical Management Tools, file 9fe27f4d-e8f6-4abd-a767-47aa49234fc3 6
Platelets beyond their count, as a key element of the innate immune system in the fight against malaria, file e1dcb338-3799-7715-e053-1705fe0a6cc9 5
Managing chronic myeloid leukemia for treatment-free remission: A proposal from the GIMEMA CML WP, file e1dcb333-f43f-7715-e053-1705fe0a6cc9 4
ETV6::ABL1-Positive Myeloid Neoplasm: A Case of a Durable Response to Imatinib Mesylate without Additional or Previous Treatment, file 3e24a95e-b0cc-4fad-b685-beebaa51868d 3
Evidence of jak2 val617phe positive essential thrombocythemia with splanchnic thrombosis during estroprogestinic treatment, file e1dcb338-309f-7715-e053-1705fe0a6cc9 3
Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: Results from the ITACa trial, file e1dcb338-3797-7715-e053-1705fe0a6cc9 3
Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 years., file e1dcb334-6b8c-7715-e053-1705fe0a6cc9 1
Totale 291
Categoria #
all - tutte 1.033
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.033


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 0 0 0 1 2 2
2020/202134 0 6 1 2 0 2 1 6 2 0 10 4
2021/202272 4 4 1 5 7 1 2 5 5 4 25 9
2022/2023115 0 7 16 15 5 7 6 6 21 10 17 5
2023/202465 4 10 8 0 10 13 6 9 5 0 0 0
Totale 291